Back to Search
VAMSEE TORRI, M.D
M.D
Medical Oncology Physician
NPI: 1467613802IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
60413(AZ)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
60413(AZ)
Education
OTHER
Class of 2001
Research & Publications (20)
Malignant peritoneal mesothelioma: a multicenter study on 81 cases.
PMID 19635740·Ann Oncol·2010
4-observational
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies.
PMID 19208728·J Clin Endocrinol Metab·2009
6-review
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
PMID 19181826·Ann Oncol·2009
3-trial
High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
PMID 19261927·Radiology·2009
4-observational
Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
PMID 18777226·Ann Med·2009
4-observational
CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
PMID 19656725·Lancet Oncol·2009
8-other
Differential diagnosis and management of focal ground-glass opacities.
PMID 19047318·Eur Respir J·2009
8-other
Do we need biopsies of metastases for colorectal cancer patients?
PMID 19584870·Br J Cancer·2009
8-other
Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer.
PMID 18663410·Invest New Drugs·2009
8-other
Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.
PMID 19596948·Anticancer Res·2009
1-meta
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.
PMID 18794541·J Clin Oncol·2008
4-observational
Impact of recent legislative bills regarding clinical research on Italian ethics committee activity.
PMID 18827108·J Med Ethics·2008
8-other
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
PMID 19033573·J Natl Cancer Inst·2008
4-observational
Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?
PMID 18487581·J Clin Oncol·2008
8-other
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
PMID 18506026·J Clin Oncol·2008
8-other
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.
PMID 18542071·Br J Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 625 N 6TH ST
PHOENIX, AZ 85004 - Phone
- (602) 406-8222
Quick Facts
- NPI
- 1467613802
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile